PD L1 News and Research

RSS
Study helps predict which ovarian cancer patients will not benefit from immune-PARP combo

Study helps predict which ovarian cancer patients will not benefit from immune-PARP combo

Study paves way for identifying ovarian cancer patients who will not benefit from combination therapy

Study paves way for identifying ovarian cancer patients who will not benefit from combination therapy

Levels of sBTLA proteins may be a marker of overall survival in patients with HCC

Levels of sBTLA proteins may be a marker of overall survival in patients with HCC

Breakthrough technology identifies proteins' nearest neighbors on cell surfaces

Breakthrough technology identifies proteins' nearest neighbors on cell surfaces

Combination of radiation and immunotherapy shows promise for advanced head and neck cancers

Combination of radiation and immunotherapy shows promise for advanced head and neck cancers

Biomarkers in blood samples can predict clinical response to immunotherapy in metastatic NSCLC

Biomarkers in blood samples can predict clinical response to immunotherapy in metastatic NSCLC

Administering immunotherapy alongside chemoradiation for advanced NSCLC appears to be safe and tolerable

Administering immunotherapy alongside chemoradiation for advanced NSCLC appears to be safe and tolerable

Global study shows long-term survival benefit for a subset of patients with advanced lung cancer

Global study shows long-term survival benefit for a subset of patients with advanced lung cancer

Researchers identify a protein that aids in colorectal cancer metastasis

Researchers identify a protein that aids in colorectal cancer metastasis

Scientists discover novel molecular pathway involved in immunotherapy response

Scientists discover novel molecular pathway involved in immunotherapy response

Researchers engineer probiotics to safely deliver immunotherapies to tumors

Researchers engineer probiotics to safely deliver immunotherapies to tumors

Avacta demonstrates initial proof-of-concept for TMAC drug conjugates in pre-clinical study

Avacta demonstrates initial proof-of-concept for TMAC drug conjugates in pre-clinical study

Community-based program enables donation of tumor tissue and blood samples for research

Community-based program enables donation of tumor tissue and blood samples for research

Stem cell transplant following treatment with PD-1 inhibitor is safe, effective for patients with Hodgkin lymphoma

Stem cell transplant following treatment with PD-1 inhibitor is safe, effective for patients with Hodgkin lymphoma

New screening method can rapidly discover potential cancer-treating compounds

New screening method can rapidly discover potential cancer-treating compounds

Study: TBK1 protein promotes cancer development, suppresses immune response to the disease

Study: TBK1 protein promotes cancer development, suppresses immune response to the disease

Study suggests two new approaches against bone metastases from prostate cancer

Study suggests two new approaches against bone metastases from prostate cancer

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Combination therapy improves survival in patients with hepatocellular carcinoma

Combination therapy improves survival in patients with hepatocellular carcinoma

Promising method to identify aggressive breast cancers that will respond to immunotherapy

Promising method to identify aggressive breast cancers that will respond to immunotherapy